Drug Shortage Report for EPINEPHRINE INJECTION USP

Last updated on 2022-04-28 History
Report ID 157571
Drug Identification Number 02435810
Brand name EPINEPHRINE INJECTION USP
Common or Proper name EPINEPHRINE INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) EPINEPHRINE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC
Packaging size 1 mL
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-03-30
Estimated end date 2022-04-25
Actual end date 2022-04-27
Shortage status Resolved
Updated date 2022-04-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-04-28 English Compare
v7 2022-04-27 French Compare
v6 2022-04-27 English Compare
v5 2022-04-19 French Compare
v4 2022-04-19 English Compare
v3 2022-03-31 English Compare
v2 2022-03-30 French Compare
v1 2022-03-30 English Compare

Showing 1 to 8 of 8